Skip to main navigation Skip to search Skip to main content

CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations

  • Kyoung Mu Lee
  • , Daehee Kang
  • , Margie L. Clapper
  • , Magnus Ingelman-Sundberg
  • , Masko Ono-Kihara
  • , Chikako Kiyohara
  • , Shen Min
  • , Qing Lan
  • , Loic Le Marchand
  • , Pinpin Lin
  • , Maria Li Lung
  • , Hatice Pinarbasi
  • , Paola Pisani
  • , Petcharin Srivatanakul
  • , Adeline Seow
  • , Haruhiko Sugimura
  • , Shinkan Tokudome
  • , Jun Yokota
  • , Emanuela Taioli
  • Seoul National University
  • National Institutes of Health
  • Karolinska Institutet
  • Kyoto University
  • Kyushu University
  • University of Hawai'i at Mānoa
  • National Health Research Institutes Taiwan
  • Hong Kong University of Science and Technology
  • Cumhuriyet University
  • University of Oxford
  • National Cancer Institute Thailand
  • National University of Singapore
  • Hamamatsu University School of Medicine
  • Nagoya City University
  • National Cancer Center Japan
  • University of Pittsburgh

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Abstract

To evaluate the roles of CYP1A1 polymorphisms [Ile462Val and T6235C (MspI)] and deletion of GSTM1 and and GSTT1 in lung cancer development in Asian populations, a pooled analysis was conducted on 13 existing studies included in Genetic Susceptibility to Environmental Carcinogenesis database. This pooled analysis included 1,971 cases and 2,130 controls. Lung cancer riskwas estimated as odds ratios (OR) and 95% confidence intervals (95% CI) using unconditional logistic regression model adjusting for age, sex, and pack-year. The CYP1A1 6235C variant was associated with squamous cell lung cancer (TC versus TT: OR, 1.42; 95% CI, 0.96-2.09; CC versus TT: OR, 1.97; 95% CI, 1.26-3.07; Ptrend = 0.003). In haplotype analysis, 462Val-6235T and Ile-C haplotypes were associated with lung cancer risk with reference to the Ile-T haplotype (OR, 3.41; 95% CI, 1.78-6.53 and OR, 1.39; 95% CI, 1.12-1.71, respectively). The GSTM1-null genotype increased squamous cell lung cancer risk(OR, 1.36; 95% CI, 1.05-1.77). When the interaction was evaluated with smoking, increasing trend of lung cancer riskas pack-year increased was stronger among those with the CYP1A1 6235 TC/CC genotype compared with those with TT genotype (Pinteraction = 0.001) and with the GSTM1-null genotype compared with the present type (P interaction = 0.08, when no genotype effect with no exposure was assumed). These results suggest that genetic polymorphisms in CYP1A1 and GSTM1 are associated with lung cancer riskin Asian populations. However, further investigation is warranted considering the relatively small sample size when subgroup analyses were done and the lack of environmental exposure data other than smoking.

Original languageEnglish
Pages (from-to)1120-1126
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number5
DOIs
StatePublished - May 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aged
  • Aged, 80 and over
  • Asian People/genetics
  • Chi-Square Distribution
  • Cytochrome P-450 CYP1A1
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Glutathione Transferase/genetics
  • Haplotypes
  • Humans
  • Logistic Models
  • Lung Neoplasms/enzymology
  • Male
  • Middle Aged
  • Polymorphism, Genetic/genetics
  • Risk
  • Smoking/adverse effects

Fingerprint

Dive into the research topics of 'CYP1A1, GSTM1, and GSTT1 polymorphisms, smoking, and lung cancer risk in a pooled analysis among Asian populations'. Together they form a unique fingerprint.

Cite this